Ambria Dermatology Overview

  • Founded
  • 2001
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $42.3M
Latest Deal Amount

Ambria Dermatology General Information

Description

Developer of a patented delivery platform. The company's delivery platform is based on pentane-1,5-diol, for improving dermal delivery of topically applied pharmaceuticals.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Kullagatan 8-10
  • 252 20 Helsingborg
  • Sweden
+46 042-38 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ambria Dermatology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 11-May-2009 $42.3M 00000 000.00 Completed Generating Revenue
3. Accelerator/Incubator 00000 Completed Startup
2. Accelerator/Incubator 20-Nov-2006 $707K $707K Completed Startup
1. Accelerator/Incubator 01-Jan-2001 Completed Startup
To view Ambria Dermatology’s complete valuation and funding history, request access »

Ambria Dermatology Executive Team (1)

Name Title Board Seat Contact Info
Stefan Appelgren Chairman
To view Ambria Dermatology’s complete executive team members history, request access »

Ambria Dermatology Board Members (1)

Name Representing Role Since
Stefan Appelgren Self Chairman 000 0000
To view Ambria Dermatology’s complete board members history, request access »

Ambria Dermatology Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aqilion Accelerator/Incubator Minority 000 0000 000000 0
Chalmers Ventures Venture Capital Minority 000 0000 000000 0
Innovationsbron Venture Capital Minority 000 0000 000000 0
To view Ambria Dermatology’s complete investors history, request access »